Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy Trials

James M. Mountz, Thomas E. Yankeelov, Daniel L. Rubin, John M. Buatti, Bradley J. Erikson, Fiona M. Fennessy, Robert J. Gillies, Wie Huang, Michael A. Jacobs, Paul E. Kinahan, Charles M. Laymon, Hannah M. Linden, David A. Mankoff, Lawrence H. Schwartz, Hyunsuk Shim, Richard L. Wahl

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)2115-2116
Number of pages2
JournalJournal of Clinical Oncology
Volume32
Issue number19
DOIs
StatePublished - Jul 1 2014

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Mountz, J. M., Yankeelov, T. E., Rubin, D. L., Buatti, J. M., Erikson, B. J., Fennessy, F. M., Gillies, R. J., Huang, W., Jacobs, M. A., Kinahan, P. E., Laymon, C. M., Linden, H. M., Mankoff, D. A., Schwartz, L. H., Shim, H., & Wahl, R. L. (2014). Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy Trials. Journal of Clinical Oncology, 32(19), 2115-2116. https://doi.org/10.1200/JCO.2014.55.8866